Our Categories
Entrepreneurs
Tech
Talent
Energy
Oil & Gas
Mining
Health
Automotive
Aerospace
Finance & Fintech
Infrastructure
Sustainability
Professional Services
E-Commerce & Retail
Agribusiness & Food
Logistics
Mobility
Trade & Investment
Policy & Economy
Cybersecurity
AI, Cloud & Data
Chemicals
Multimedia
Podcast
Videos
Audio Articles
Opinion
Expert Contributor
Startup Contributor
Goverment
Embassy
Chamber of Commerce
Industry Association
Type
Spotlight
Entrepreneurs
Tech
Talent
Energy
Oil & Gas
Mining
Health
Automotive
Aerospace
Finance & Fintech
Infrastructure
Sustainability
Professional Services
E-Commerce & Retail
Agribusiness & Food
Logistics
Mobility
Trade & Investment
Policy & Economy
Cybersecurity
AI, Cloud & Data
Chemicals
Loading...
Loading...
Sector by:
Pfizer, BioNTech Seek EU Approval for KP.2 Vaccine
By
MBN Staff
- Tue, 09/24/2024 - 11:54
The Omicron KP.2 COVID-19 vaccine being developed by Pfizer and BioNTech could be used to immunize individuals aged six months and older.
Featured content
Most popular
Sector by:
